PROCYON CORPORATION

PCYN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $3.4M $2.8M $2.8M $2.7M $2.8M $2.7M
Cost of Revenue $1.0M $808.5K $708.9K $700.9K $701.9K $596.9K
Gross Profit $2.4M $2.0M $2.1M $2.0M $2.1M $2.1M
Gross Margin 70.1% 70.8% 75.0% 74.5% 74.9% 77.9%
Operating Expenses
Research & Development $20.0K $22.8K $21.2K $2.2K $200
SG&A Expense $1.1M $1.1M $911.3K $889.4K $884.8K $818.9K
Operating Income $-103.6K $-341.4K $65.3K $-12.5K $231.4K $335.0K
Operating Margin -3.0% -12.3% 2.3% -0.5% 8.3% 12.4%
Interest Expense $4.5K $200 $-3.4K $16.6K $27.6K
Pretax Income $190.2K $-339.5K $68.9K $-12.7K $217.1K $311.0K
Income Tax Expense $80.6K $121.2K $-45.3K $91.6K $88.6K $118.1K
Net Income $109.6K $-218.3K $23.6K $-104.3K $128.5K $192.9K
Net Margin 3.2% -7.9% 0.8% -3.8% 4.6% 7.1%
EPS (Basic) $0.01 $-0.03 $0.00 $-0.02 $0.01 $0.02
EPS (Diluted) $0.01 $-0.03 $0.00 $-0.02 $0.01 $0.02
Shares Outstanding (Basic) 8.1M 8.1M 8.1M 8.1M 8.1M 8.1M
Shares Outstanding (Diluted) 8.3M 8.1M 8.3M 8.1M 8.3M 8.3M
Dividends Per Share
← Newer Page 2 of 2 Older →